Sterling Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87K Sell
678
-770
-53% -$3.33K ﹤0.01% 2755
2026
Q1
$5.6K Sell
1,448
-285
-16% -$1.17K ﹤0.01% 2672
2025
Q4
$7.24K Buy
1,733
+720
+71% +$2.79K ﹤0.01% 2762
2025
Q3
$3.33K Buy
1,013
+411
+68% +$1.16K ﹤0.01% 2888
2025
Q2
$855 Sell
602
-1,549
-72% -$2.2K ﹤0.01% 3083
2025
Q1
$3.21K Sell
2,151
-1,819
-46% -$2.86K ﹤0.01% 2379
2024
Q4
$4.45K Buy
3,970
+3,590
+945% +$3.06K ﹤0.01% 2516
2024
Q3
$360 Buy
+380
New +$479 ﹤0.01% 2986

Other funds holding PGEN

Sterling Capital Management's PGEN Position: Q2 2026 in Review

Sterling Capital Management reduced its Precigen (PGEN) stake by 53% in Q2 2026, selling an estimated $3.33K and leaving 678 shares worth $3.87K. The position accounts for ﹤0.01% of the portfolio, ranked #2755.

Sterling Capital Management first reported a position in PGEN in Q3 2024 and has held it in 8 quarters since. The position peaked at $7.24K in Q4 2025. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Sterling Capital Management held 678 shares of Precigen worth $3.87K as of Q2 2026.
  • Sterling Capital Management sold 770 Precigen shares in Q2 2026, an estimated $3.33K.
  • Precigen made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2755 holding.
  • Sterling Capital Management first reported a position in Precigen in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Precigen position peaked at $7.24K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.